Tiziana Life Sciences Ltd (NASDAQ:TLSA) Short Interest Down 20.0% in April

Tiziana Life Sciences Ltd (NASDAQ:TLSA) was the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 257,800 shares, a decline of 20.0% from the March 31st total of 322,200 shares. Based on an average daily volume of 149,600 shares, the days-to-cover ratio is currently 1.7 days.

Tiziana Life Sciences Stock Performance

TLSA traded up $0.01 during trading on Tuesday, hitting $0.66. 174,340 shares of the company’s stock were exchanged, compared to its average volume of 147,235. Tiziana Life Sciences has a fifty-two week low of $0.41 and a fifty-two week high of $1.27. The business’s 50 day moving average is $0.52 and its two-hundred day moving average is $0.57.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.